Having assessed the situation on its core markets, the fit of the company's near-term development portfolio and the existing operating portfolio ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, reported today on ...

CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the Company will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025, at 1:30 pm PT in San ...

GMT/BST   Britvic plc 7 January 2025   DIRECTOR/PDMR ...

Senior Biotechnology and Specialty Healthcare Financial Executive Brings Extensive Experience in Leading Acquisition and Organic Growth ...

Company to Host International Roadshow the Week of January 13, 2025 LOS ANGELES, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: ...

ZenaTech signed the LOI shortly before the end of the year. The Company anticipates closing on the acquisition before the end of January 2025. "This acquisition is part of a larger strategy to expand ...

Published extended data from the phase 2 EMPhASIS trial of vidofludimus calcium in relapsing-remitting MS in the peer reviewed journal, Neurology® Neuroimmunology & Neuroinflammation, an official ...

EQS-News: clearvise AG / Key word (s): Alliance clearvise AG acquires 18.6 MW Weilrod 2 wind farm and expands IPP portfolio to over 400 MW 07.01.2025 / 08:30 CET/CEST The issuer is solely ...

The Company announces that on 6 January 2025 it bought back 15,000 of its own shares, to be held as treasury shares, at an average price of 1314 pence per share. Further details are set out below: ...

Gold prices moved to the downside during trading on Monday, extending the pullback seen during last Friday's session. Gold for ...

The China stock market has finished lower in four straight sessions, plummeting more than 200 points or 6 percent in that span. The ...